MicroRNA as a Potential Diagnostic and Prognostic Biomarker in Diffuse Large B‐Cell Lymphoma: A Systematic Review and Meta‐Analysis
ABSTRACT Background Recently, microRNAs (miRNAs) have been applied as biomarkers for diffuse large B‐cell lymphoma (DLBCL) patients. Early diagnosis and management of DLBCL can improve patient survival and prognosis. Aims This systematic review and meta‐analysis aimed to evaluate the diagnostic and...
Saved in:
Main Authors: | Shaghayegh Khanmohammadi, Mahdi Masrour, Parisa Fallahtafti, Fatemeh Hasani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.70070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
by: Zhenglin He, et al.
Published: (2025-01-01) -
MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions
by: Emmanouil P. Vardas, et al.
Published: (2024-12-01) -
Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma
by: Erman OZTURK, et al.
Published: (2022-03-01) -
Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
by: Anna Darlene van der Heiden, et al.
Published: (2025-02-01) -
MicroRNAs in Autoimmune Sjögren’s Syndrome
by: Seunghee Cha, et al.
Published: (2018-12-01)